Related Experiment Videos

Acute coronary syndromes and diabetes mellitus

Benjamin H Trichon1, Matthew T Roe

  • 1Duke University Medical Center, Duke Clinical Research Institute, 2400 Pratt St--Room 7037, Durham, NC 27705, USA.

Diabetes & Vascular Disease Research
|November 25, 2005
PubMed

Insights

Patients with diabetes mellitus face higher risks from acute coronary syndromes, including myocardial infarction. Despite potential benefits from treatments, they receive them less often, necessitating improved care quality for better outcomes.

Area of Science:

  • Cardiology
  • Diabetology
  • Public Health

Background:

  • Patients with diabetes mellitus (DM) have increased risks for adverse outcomes following acute coronary syndromes (ACS), such as ST-segment elevation myocardial infarction (STEMI) and non-ST-segment elevation acute coronary syndromes (NSTE-ACS).
  • Individuals with DM appear to gain more significant advantages from established evidence-based therapies for ACS compared to those without DM.

Purpose of the Study:

  • To highlight the disparity in treatment quality for diabetic patients experiencing acute coronary syndromes.
  • To emphasize the need for enhanced strategies to improve the delivery and effectiveness of proven therapies in this high-risk population.

Main Methods:

  • This study reviews existing literature and clinical data on the treatment patterns and outcomes of patients with DM and ACS.
  • Analysis focuses on the utilization of evidence-based therapies in diabetic versus non-diabetic patients presenting with STEMI or NSTE-ACS.

Main Results:

  • Diabetic patients with ACS exhibit a higher incidence of adverse cardiovascular events.
  • Despite demonstrated benefits, patients with DM are less frequently administered recommended, evidence-based treatments for ACS.

Conclusions:

  • There is a critical gap in the quality of care for patients with diabetes mellitus who have acute coronary syndromes.
  • Renewed and focused efforts are essential to optimize the use of proven therapies and improve clinical outcomes for diabetic individuals with ACS.

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
Complications of Diabetes Mellitus01:22

Complications of Diabetes Mellitus

Diabetes mellitus is a chronic metabolic disorder characterized by persistent hyperglycemia due to insulin deficiency, resistance, or both. Prolonged hyperglycemia disrupts metabolic homeostasis and leads to acute and chronic complications.Acute ComplicationsAcute complications result from sudden metabolic imbalance.Diabetic ketoacidosis (DKA) mainly appears in type 1 diabetes but may also develop in type 2 diabetes, particularly under extreme stress. It arises from severe insulin deficiency,...
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...